Pemetrexed or Erlotinib as Second-Line Therapy in Treating Patients With Advanced Non-Small Cell Lung Cancer

This study is ongoing, but not recruiting participants.

Sponsor:

Collaborators:

Southwestern Oncology Group (SWOG)

Cancer and Leukemia Group B

Eastern Cooperative Oncology Group

NCIC Clinical Trials Group

Information provided by (Responsible Party):

National Cancer Institute (NCI)

ClinicalTrials.gov Identifier:

NCT00738881

First received: August 20, 2008

Last updated: January 14, 2013

Last verified: November 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Primary Completion Date:	December 2011 (Final data collection date for primary outcome measure)